Power Law company profile

ITM Radiopharma

Biotech & Life Sciences · Garching bei München, Germany · Founded 2004 Thoroughbred

Development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer treatment

Valuation

$100–500M

Latest valuation · 2026

Unlock exact value

Revenue

$100–500M

Latest reported FY

Unlock exact value

Headcount

500–1k

Current team size

Unlock exact value

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

9 investors on ITM Radiopharma's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 9 investors entered at this stage

BlackRock

China Grand Pharmaceutical and Healthcare Holdings

Temasek

Petrichor

Qatar Investment Authority

ATHOS Venture

MedTech

Carbyne Partners

Nextech Invest

Global footprint

Where ITM Radiopharma has talent and traffic

Workforce by country

12 countries with
team presence

🇩🇪 Germany89.7%

🇺🇸 United States5.4%

🇫🇷 France1.6%

🇬🇧 United Kingdom0.9%

🇦🇹 Austria0.5%

Top 5 of 12 shown

Web traffic by country

12K monthly visits
across markets

🇺🇸 United States40.8%

🇩🇪 Germany29.2%

🇮🇳 India9.2%

🇬🇧 United Kingdom8.3%

🇨🇦 Canada5%

Top 5 markets shown

Market sentiment

What the market is saying about ITM Radiopharma

An AI-synthesized read of the highest-engagement posts about ITM Radiopharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See ITM Radiopharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles